Why Oncology Institute’s (TOI) Analyst Upgrades Put Its Community Cancer Care Growth Story in Focus

The Oncology Institute, Inc. (NASDAQ:TOI) is one of the best medical care facilities stocks to buy according to analysts. It ranks first by average analyst upside in this screen, with analysts seeing roughly 46.8% upside. The latest stronger investor-relevant development came on June 17, when Needham raised its price target on the stock to $7 from $5 while maintaining a Buy rating. That followed another positive analyst move on June 8, when BTIG raised its price target to $8 from $7 and also kept a Buy rating.

Why Oncology Institute’s (TOI) Analyst Upgrades Put Its Community Cancer Care Growth Story in Focus

The updates are relevant because The Oncology Institute’s investment case depends on whether its community-based oncology platform can keep scaling value-based cancer care while narrowing losses and improving cash generation. The company remains smaller and riskier than large hospital operators, but the recent analyst target increases suggest confidence in the platform’s growth outlook. For a medical care facilities list ranked by analyst upside, that is a cleaner hook than routine investor conference participation.

The Oncology Institute, Inc. (NASDAQ:TOI) provides community-based oncology care through clinics and affiliated locations across several U.S. states.

While we acknowledge the risk and potential of TOI as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than TOI and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1